Navigation Links
Reportlinker Adds Innovative Drug Discovery in Emerging Markets
Date:1/11/2011

NEW YORK, Jan. 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Innovative Drug Discovery in Emerging Markets

http://www.reportlinker.com/p0359990/Innovative-Drug-Discovery-in-Emerging-Markets.html

Introduction Emerging markets have represented important growth opportunities for the global pharmaceutical industry, but it has been unclear the extent to which this has been accompanied by growth in domestic innovation within these countries. This report examines the most prominent domestic innovators, assessing key research strategies, front-running candidates, scientific strengths, and patent portfolios.

Features and benefits * Assess the extent of innovative drug discovery occurring in each if the emerging markets and compare the output of pharmaceutical patent applications.

* Understand the factors that have encouraged or hindered innovative research and gain insight into the wider environment faced by innovators.

* Identify the most prominent innovative companies in each country and understand the role of innovation within their broader business strategies.

* Identify each company's therapeutic priorities, research strategies, scientific strengths, key pipeline projects, and intellectual property.

* Gain insight into the most promising innovative preclinical and clinical candidates and the science on which they are based.

Highlights Of the large number of companies assessed for evidence of innovative drug discovery, only a small proportion met our criteria for inclusion. In total 47 profiles are provided. A common feature is that these companies have a source of revenue aside from innovative drugs. Pure research-based innovators funded solely by venture capital are rare.

Drugs derived from botanical sources feature heavily in the pipelines of innovative companies from several of the emerging markets. These drugs range from multi-component extracts to synthetic compounds based on natural product leads. Some companies are applying a high-technology approach to understanding the mechanism of action of botanical drugs.

While China in particular can boast the successful innovation of novel drugs (gene therapies) ahead of companies in the West, it is notable that regulatory approvals for successful drugs have been limited to the country of origin. A novel drug of global importance is yet to appear from the emerging markets, but the potential in niche areas is high.

Your key questions answered * Have countries with large growth in their pharmaceutical markets also undergone growth in the pursuit of innovative drugs?

* Which countries have fostered an environment conducive to innovative drug discovery, and how have the domestic pharmaceutical industries evolved?

* Which are the most prominent domestic innovators, what is their background, and what therapeutic advances are they aiming to achieve?

* What pipeline drugs do domestic companies have, what is their current status, and what will they be competing with if they reach the market?

* What are the chemical structures of lead entities, what international patents have been filed, and which companies are seeking collaborations?

To order this report:: Innovative Drug Discovery in Emerging Markets

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Contact:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805) 652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... Patient warming ... of blood during surgeries, lowering the risks of neurological disorders ... of SSIs. The patient warming systems can be segmented into ... benefits in turn reduce the stay at hospitals thus, lowering ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... poised to grow in 2017-2023. Various reasons for growth ... obese population, higher incidences of chronic diseases, high recovery ... mobility aid services. Medical lifting sling refers to ... with limited mobility. These slings connect to the lift ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... will become Quality Insights beginning January 1, 2017. The name change aligns ... commitment to measuring and improving health care quality. , “We are very proud ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc ... Language Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: ... , Results of the comparative usability study demonstrate that a dictation-based method (“NLP ...
Breaking Medicine News(10 mins):